Newsquawk Logo

CVS Health (CVS) Q1 2026 (USD): adj. EPS 2.57 (exp. 2.18), Revenue 100.4bln (exp. 94.97bln). Lifts guidance: Current FY EPS 7.30-7.50 (exp. 7.16)

CVS Health has delivered a strong earnings report, beating both EPS and revenue expectations, which suggests robust operational performance.

Newsquawk StaffPublished On the live feed at — 6 more headlines followed before this page went public
Newsquawk headlinesUTC

Walt Disney Company (DIS) Q2 2026 (USD): Adj. EPS 1.57 (exp. 1.49), Revenue 25.2bln (exp. 24.84bln), Adj. operating income 4.6bln (exp. 4.39bln)

Apollo Global Management Inc (APO) Q1 2026 (USD): Adj. EPS 1.94 (exp. 1.98), Revenue -- (exp. 5.23bln)

CVS Health (CVS) Q1 2026 (USD): adj. EPS 2.57 (exp. 2.18), Revenue 100.4bln (exp. 94.97bln). Lifts guidance: Current FY EPS 7.30-7.50 (exp. 7.16)

Slovakia to cancel volume limits for diesel purchases and remove higher prices for foreign vehicles as of the 8th of May

Pakistani journalist Mallick posts "US - Iran are close to an “agreement” to end the war with Pakistan's mediation..."

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Try the platform free
Free. No signup, no card.
Context

Additionally, the upward revision of FY EPS guidance indicates management's confidence in sustaining this momentum, potentially leading to positive sentiment in the stock and impacting related sectors in healthcare and retail. Investors should consider how this performance aligns with broader market trends and peer performance within the healthcare space.

External

Related headlines

The whole workspace, free to try.

Try it free
Newsquawk Logo

© 2026 Newsquawk. All rights reserved.